Changes in S1PR2 and S1PR1 expression in diabetic rats contribute to DKD progression, with S1PR2 inhibition and S1PR1 activation showing protective effects against renal injury in mouse models [92]. Here, S1PR1 is linked to diabetic kidney disease.